孕34～35周早产者亦应给予促进胎肺成熟(附93例分析)  

The influence of promoting maturation of fetal lungs on prognosis of premature infants at 34～35 month term(Analysis 93 cases).

作　　者：李钦文[1] 

机构地区：[1]山东省泰安市中心医院产科,泰安271000

出　　处：《中国优生与遗传杂志》2009年第9期77-78,共2页Chinese Journal of Birth Health & Heredity

摘　　要：目的探讨孕34～35周早产者,是否应用促胎肺成熟药,对早产儿预后的影响。方法2006年5月至2009年1月在我院住院分娩,孕周在34～35周的早产儿173例。随机分为A、B两组,A组(93例)于分娩前给予促胎肺成熟药,B组(80例)为对照组,分娩前不用促胎肺成熟药。观察两组早产儿出生后的并发症发生情况及平均住院时间。结果A组及B组比较,早产儿的窒息率,肺透明膜病(RDS)及脑出血发生率均交低(P<0.01),病理性黄疸发生率低(P<0.05);平均特护时间及住院天数低(P<0.05),早产儿体重无差异(P>0.05)。结论孕34～35周早产者也应预防性用促胎肺成熟药以减少并发症的发生。Objective ： To investigate the influence of glucocorticoid promoting maturation of fetal lungs on prognosis of premature infants at 34 - 35 month term. Mothods ： A total of 173 premature infants, deliveried at 34 - 35 month from May 2006 to January 2009 in our hospital , were divided into two groups randomly. Group A （93 infants） glucocorticoid treatment before delivery and Group B （80 infants） without glucocorticoid. The two groups were observed in preterm infants after birth, the incidence of complications and the average length of stay in hospital. Results： Comparing the two groups, the incidents of Asphyxia, hyaline membrane disease （RDS） and pathologic jaundice all lower in group A （ P 〈 0.01 ）. The incidence of jaundice was lower too （ P 〈 0. 05） , the average care time and length of hospital stay （ P 〈 0.05）. But the wight of premature infants was no significant difference （ P 〉 0. 05）. Conclusions： Pregnant premature at 34 -35 weeks should also be preventive treatment and promote fetal lung maturity in order to reduce the incidence of complications.

关 键 词：早产 糖皮质激素 促胎肺成熟 新生儿窒息 肺透明膜病变(RDS) 病理性黄疸 

分 类 号：R722.6[医药卫生—儿科]